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Objective: To report on the effects of the ketogenic diet on a 9-year-old boy with myoclonic jerks due to subacute sclerosing
panencephalitis (SSPE).
Methods: A 9-year-old boy presented with progressively worsening myoclonus unresponsive to valproic acid and clonazepam.
He was started on the ketogenic diet maintaining urine ketones at greater than 80 mg dl−1.
Results: Within 2 weeks of dietary initiation, myoclonic jerks stopped. Four weeks later he developed cognitive slowing. Results
of electroencephalogram and cerebrospinal fluid analysis were consistent with SSPE. Three months after ketogenic diet initiation,
myoclonic jerks reappeared and were refractory to treatment.
Conclusion: The ketogenic diet may be useful in controlling, even temporarily, the myoclonic jerks of SSPE.
© 2002 BEA Trading Ltd. Published by Elsevier Science Ltd. All rights reserved.
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INTRODUCTION
Subacute sclerosing panencephalitis (SSPE) is a slow
virus disease related to the measles virus causing
progressive inflammation and sclerosis of the brain.
Patients initially present with progressive cognitive de-
cline and myoclonus and invariably evolve into a veg-
etative, decorticated state1. The electroencephalogram
(EEG) during the second stage of the disease charac-
teristically consists of high voltage, repetitive polypha-
sic and sharp- and slow-wave complexes recurring
every 4–15 seconds accompanied by myoclonic
jerks2. Treatment regimens using either isoprinosine
or inosiplex in combination with alpha-interferon
appear to slow disease progression3, 4. The my-
oclonus responds variably to antiepileptic medi-
cations1, 5.
We report a patient with SSPE whose myoclonus
improved significantly, albeit temporarily, after being
placed on the ketogenic diet.
CASE REPORT
A 9-year-old boy presented with a 4-month history of
progressively worsening generalised myoclonic move-
ments which were arrhythmic, occurring at rest and
affecting ambulation as well as head and hand control.
The patient was tried on valproic acid and clonazepam
individually and in combination without improvement.
A magnetic resonance imaging (MRI) scan of the
brain was normal, while the EEG showed mild slowing
as well as bursts of generalised, high voltage polypha-
sic slow waves coincident with the myoclonic jerks.
No epileptiform or periodic discharges were seen.
Because of worsening symptoms, the patient was
started on a 750 cal 4:1 ketogenic diet with urinary
ketones maintained at greater than 80 mg dl−1.
Within 2 weeks of dietary initiation, the myo-
clonic jerks stopped. The patient could walk without
assistance and had normal head and hand control,
resulting in improved well being.
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Fig. 1: The electroencephalogram performed 6 weeks after ketogenic diet initiation shows high voltage repetitive polyphasic
discharges recurring every 7 seconds.
Six weeks after dietary initiation, the patient de-
veloped cognitive slowing. During this time the EEG
showed generalised periodic sharp-wave discharges
recurring every 7 seconds that occurred despite the
absence of myoclonic jerks (Fig. 1). The serum IgG
measles titer was elevated at 1250 ELISA units and
the cerebrospinal IgG measles titer was also elevated
at 1550 ELISA units (cut-off value: 200 ELISA units).
At this point, the patient underwent treatment
using a combination of inosiplex and intrathecal
alpha-interferon. However, the symptoms progressed
despite treatment. Three months after ketogenic diet
initiation, the myoclonic jerks reappeared and pro-
gressed despite the persistence of urinary ketones.
Five months after initiation, the ketogenic diet was
discontinued for lack of efficacy.
DISCUSSION
Our patient with SSPE experienced a temporary but
significant decrease in myoclonic jerks when placed
on the ketogenic diet resulting in improved well be-
ing. The clinical presentation was somewhat atypical
in that the appearance of myoclonus preceded cog-
nitive decline. The diet was initiated relatively early
in the course of the disease before the appearance of
generalised periodic complexes.
Interestingly, myoclonus was still absent at the time
the EEG already showed periodic complexes suggest-
ing that while the diet may decrease the myoclonic
jerks, it does not significantly alter the EEG findings of
SSPE. Thus, despite the fact that the myoclonic jerks
and periodic discharges of SSPE generally occur coin-
cident with each another, it is possible that the patho-
physiology underlying these phenomena may in fact
be different. The decreased efficacy of the ketogenic
diet with disease progression suggests that use of the
diet does not alter the course of the disease but merely
provides symptomatic control of the myoclonic jerks.
To my knowledge this is the first reported case of
the use of the ketogenic diet for control of myoclonus
in a patient with SSPE. The ketogenic diet is use-
ful particularly in children with difficult-to-control
symptomatic forms of epilepsy6, a good number of
which have prominent myoclonic features. Though
Use of the ketogenic diet in SSPE 177
the mechanism of action of the ketogenic diet is
yet to be satisfactorily explained, it appears that the
use of ketone bodies as the main source of fuel for
the brain increases the cerebral afterdischarge and
seizure threshold7. This likely explains the temporary
cessation of the myoclonic jerks of our patient. With
disease progression it appears that the ability of ke-
tone bodies to alter the seizure threshold is not potent
enough, resulting in a recurrence of myoclonic jerks.
The myoclonic jerks of SSPE are known to be
severely disabling and oftentimes refractory to treat-
ment1. This case study suggests that the ketogenic
diet might temporarily relieve the myoclonic jerks
of individuals afflicted with this disease, and be use-
ful for other syndromes in which myoclonus is the
significant disabling symptom.
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